In vivo detection of malignant thymic masses by indium-111-DTPA-D- Phe1-octreotide scintigraphy (396 views visite)
J Nucl Med (ISSN: 0161-5505, 1535-5667, 1535-5667electronic), 1998 Apr; 39(4): 634-639.
Export to Esporta in BibTeX Export to Esporta in EndNote
Paper type Tipo di articolo: Journal Article,
Impact factor: 3.064, 5-year impact factor Impact factor a 5 anni: 5.331
Url: http://www.scopus.com/inward/record.url?eid=2-s2.0-0031948219&partnerID=40&md5=4ddf0b5e9e57b0925e62b82575ce8e14
Keywords Parole chiave: Indium-111-Octreotide, Myasthenia Gravis, Somatostatin Receptors, Thymoma, Indium 111, Pentetate Indium, Adult, Article, Cancer Staging, Clinical Article, Clinical Feature, Computer Assisted Tomography, Diagnostic Value, Female, Human, Isotope Labeling, Nuclear Magnetic Resonance Imaging, Priority Journal, Thymus Hyperplasia, Adolescent, Carcinoid Tumor, Differential, Iodine Radioisotopes, Middle Aged, Pentetic Acid, Radiopharmaceuticals, Thymus Neoplasms, Emission-Computed, Single-Photon, X-Ray Computed,
Affiliations Affiliazioni:
Via Modigliani 66/68, Aversa (CE), 81031, Italy
References Riferimenti:
Rosenberg, J.C., Neoplasms of mediastinum (1989) Cancer Principles and Practical Oncology, 3rd Ed., pp. 706-724. , De Vita VT, Hellmann S, Rosenberg SA, eds. Philadelphia: J.B. Lippincott C
Hoda, S.A., Warren, G.P., Zaman, M.B., Extrathoracic metastatic malignant thymoma diagnosis by aspiration cytology (1991) Arch Pathol Lab Med, 115, pp. 399-401
Rosai, J., Levine, G.D., Tumors of the thymus (1976) Atlas of Tumor Pathology, pp. 1-166. , Rosai J, ed. Washington, DC: Armed Forces Institute of Pathology
Chilosi, M., Iannucci, A., Fiore Donati, L., Myasthenia gravis: Immunohistological heterogeneity in microenvironmental organization of hyperplastic and neoplastic thymuses suggesting different mechanisms of tolerance breakdown (1986) J Neuroimmunol, 11, pp. 191-204
Janossy, G., BoFill, M., Trejdosiewicz, L.K., Willcox, H.N.A., Chilosi, M., Cellular differentiation of lymphoid subpopulations and their microenvironments in the human thymus (1986) The Human Thymus. Histophysiology and Pathology, pp. 89-125. , Muller-Hermelink HK, ed. Berlin: Springer
Scarpa, A., Chilosi, M., Cappelli, P., Expression and gene rearrangement of the T-cell receptor in human thymomas (1990) Virch Arch B Cell Pathol, 58, pp. 235-239
Lauriola, L., Maggiano, N., Larocca, L.M., Cells immunoreactive for neuropeptide in human thymomas (1990) J Clin Pathol, 43, pp. 829-832
Greaves, M.F., Target cells, differentiation and clonal evolution in chronic granulocytic leukemia: A model for understanding the biology of malignancy (1982) Chronic Granulocytic Leukemia, pp. 15-47. , Shaw MT, ed. New York: Praeger
Pierce, G.B., Nakane, P.K., Martinez-Hernandez, A., Ward, J.M., Ultrastructural comparison of differentiation of stem cells of murine adenocarcinomas of colon and breast with their normal counterparts (1977) J Natl Cancer Inst, 58, pp. 1329-1345
Larsson, L.I., Regulatory peptides and amines during ontogeny and in nonendocrine cancers: Occurrence and possible functional significance (1988) Prog Histochem Cytochem, 17, pp. 89-111
Zachary, J., Wol, P.J., Rozengurt, E., A role for neuropeptides in the control of cell proliferation (1987) Dev Biol, 124, pp. 295-308
Reubi, J.C., Waser, B., Horisberger, U., In vitro autoradiographic and in vivo scintigraphic localization of somatostatin receptors in human lymphatic tissue (1993) Blood, 82, pp. 2143-2151
Lamberts, S.W.J., Krenning, E.P., Reubi, J.C., The role of somatostatin and its analogues in the diagnosis and treatment of tumors (1991) Endocrinol Rev, 12, pp. 450-482
Reubi, J.C., Laissue, J., Krenning, E.P., Lamberts, S.W.J., Somatostatin receptors in human cancer: Incidence, characteristics, functional correlates and clinical implications (1992) J Steroid Biochem Mol Biol, 43, pp. 27-35
Krenning, E.P., Kwekkeboom, D.J., Bakker, W.H., Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [l23I-Tyr3]-octreotide: The Rotterdam experience with over 1000 patients (1993) Eur J Nucl Med, 20, pp. 716-731
Krenning, E.P., Bakker, W.H., Breeman, W.A.P., Localization of endocrine-related tumors with radioiodinated analogue of somatostatin (1989) Lancet, 1, pp. 242-244
Lamberts, S.W.J., Bakker, W.H., Reubi, J.C., Somatostatin receptor imaging in the localization of endocrine tumors (1990) N Engl J Med, 323, pp. 1246-1249
Lamberts, S.W.J., Chayvialle, J.A., Krenning, E.P., The visualization of gastroenteropancreatic endocrine tumors (1992) Metabolism, 9 (2 SUPPL.), pp. 111-115
Jamar, F., Fiasse, R., Leners, L., Pauwels, S., Somatostatin receptor imaging with In-111 pentetreotide in gastroenteropancreatic neuroendocrine tumors: Safety, efficacy and impact on patient management (1995) J Nucl Med, 36, pp. 542-549
Kwekkeboom, D.J., Kho, G.S., Lamberts, S.W.J., The value of octreotide scintigraphy in patients with lung cancer (1994) Eur J Nucl Med, 21, pp. 1106-1113
Flamen, P., Bossuyt, A., De Greve, J., Pipeleers-Marichal, M., Keuppens, F., Somers, G., Imaging of renal cell cancer with radiolabeled octreotide (1993) Nucl Med Commun, 14, pp. 873-877
Vanhagen, P.M., Krenning, E.P., Reubi, J.C., Somatostatin analogue scintigraphy of malignant lymphoma (1993) Br J Haematol, 83, pp. 75-79
Van Eijck, C.H., Krenning, E.P., Bootsma, A., Somatostatin receptor scintigraphy in primary breast cancer (1994) Lancet, 343, pp. 640-643
Lee, J.D., Kim, D.I., Lee, J.T., Chang, J.W., Park, C.Y., Indium-111-pentetreotide imaging in intra-axial brain tumors: Comparison with thallium-201 SPECT and MRI (1995) J Nucl Med, 36, pp. 537-541
Setyono-Han, B., Henckelman, M.S., Foekens, J.A., Klijn, J.G.M., Direct inhibitory effects of somatostatin (analogues) on the growth of human breast cancer cells (1987) Cancer Res, 47, pp. 1566-1570
Reubi, J.C., Landolt, A.M., The growth hormone responses to octreotide in acromegaly correlate with adenoma somatostatin receptor status (1991) J Clin Endocrinol Metab, 68, pp. 844-850
Wang, L.S., Huang, M.H., Lin, T.S., Huang, B.S., Chien, K.Y., Malignant thymomas (1992) Cancer, 70, pp. 443-450
Moina, P.L., Siergel, M.J., Glazer, H.S., Thymic mass on MR imaging (1990) Am J Roentgenol, 155, pp. 495-500
Sakai, F., Sine, S., Kiyono, K., MR imaging of thymoma: Radiologie-pathologie correlation (1992) Am J Roentgenol, 158, pp. 751-756
Batra, P., Hermann Jr., C., Mulder, D., Mediastinal imaging in myasthenia gravis: Correlation of chest radiography, CT, MR and surgical findings (1987) Am J Roentgenol, 148, pp. 515-519
Lin, R.S., Yen, S.H., Huang, M.H., Use of fluorine-18 fluorodeoxyglucose positron emission tomography in the detection of thymoma: A preliminary report (1995) Eur J Nucl Med, 22, pp. 1402-1407
Michigishi, T., Mizukami, Y., Shuke, N., Visualization of the thymus with therapeutic doses of radioiodine in patients with thyroid cancer (1993) Eur J Nucl Med, 20, pp. 75-79
Rettenbacher, L., Galvan, G., Differentiation between residual cancer and thymic hyperplasia in malignant non-Hodgkin's lymphoma with somatostatin receptor scintigraphy (1994) Clin Nucl Med, 19, pp. 64-65
Pearse, A.G.E., The cytochemistry and ultrastructure of polypeptide hormone producing cells of the APUD series and the embryologic, physiologic and pathologic implication of the concept (1969) J Histochem Cytochem, 17, pp. 303-312
Ballard, H.S., Frame, B., Hartrock, R.J., Familial multiple endocrine adenoma-peptic ulcer complex (1964) Medicine, 43, pp. 481-516
Palmieri, G., Lastoria, S., Colao, A., Successful treatment of a patient with malignant thymoma and pure red cell aplasia with octreotide and prednisone (1997) N Engl J Med, 336, pp. 263-265
Rosenberg, J. C., Neoplasms of mediastinum (1989) Cancer Principles and Practical Oncology, 3rd Ed., pp. 706-724. , De Vita VT, Hellmann S, Rosenberg SA, eds. Philadelphia: J. B. Lippincott C
Hoda, S. A., Warren, G. P., Zaman, M. B., Extrathoracic metastatic malignant thymoma diagnosis by aspiration cytology (1991) Arch Pathol Lab Med, 115, pp. 399-401
Greaves, M. F., Target cells, differentiation and clonal evolution in chronic granulocytic leukemia: A model for understanding the biology of malignancy (1982) Chronic Granulocytic Leukemia, pp. 15-47. , Shaw MT, ed. New York: Praeger
Pierce, G. B., Nakane, P. K., Martinez-Hernandez, A., Ward, J. M., Ultrastructural comparison of differentiation of stem cells of murine adenocarcinomas of colon and breast with their normal counterparts (1977) J Natl Cancer Inst, 58, pp. 1329-1345
Larsson, L. I., Regulatory peptides and amines during ontogeny and in nonendocrine cancers: Occurrence and possible functional significance (1988) Prog Histochem Cytochem, 17, pp. 89-111
Reubi, J. C., Waser, B., Horisberger, U., In vitro autoradiographic and in vivo scintigraphic localization of somatostatin receptors in human lymphatic tissue (1993) Blood, 82, pp. 2143-2151
Lamberts, S. W. J., Krenning, E. P., Reubi, J. C., The role of somatostatin and its analogues in the diagnosis and treatment of tumors (1991) Endocrinol Rev, 12, pp. 450-482
Reubi, J. C., Laissue, J., Krenning, E. P., Lamberts, S. W. J., Somatostatin receptors in human cancer: Incidence, characteristics, functional correlates and clinical implications (1992) J Steroid Biochem Mol Biol, 43, pp. 27-35
Krenning, E. P., Kwekkeboom, D. J., Bakker, W. H., Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1] - and [l23I-Tyr3] -octreotide: The Rotterdam experience with over 1000 patients (1993) Eur J Nucl Med, 20, pp. 716-731
Krenning, E. P., Bakker, W. H., Breeman, W. A. P., Localization of endocrine-related tumors with radioiodinated analogue of somatostatin (1989) Lancet, 1, pp. 242-244
Kwekkeboom, D. J., Kho, G. S., Lamberts, S. W. J., The value of octreotide scintigraphy in patients with lung cancer (1994) Eur J Nucl Med, 21, pp. 1106-1113
Vanhagen, P. M., Krenning, E. P., Reubi, J. C., Somatostatin analogue scintigraphy of malignant lymphoma (1993) Br J Haematol, 83, pp. 75-79
Van Eijck, C. H., Krenning, E. P., Bootsma, A., Somatostatin receptor scintigraphy in primary breast cancer (1994) Lancet, 343, pp. 640-643
Lee, J. D., Kim, D. I., Lee, J. T., Chang, J. W., Park, C. Y., Indium-111-pentetreotide imaging in intra-axial brain tumors: Comparison with thallium-201 SPECT and MRI (1995) J Nucl Med, 36, pp. 537-541
Reubi, J. C., Landolt, A. M., The growth hormone responses to octreotide in acromegaly correlate with adenoma somatostatin receptor status (1991) J Clin Endocrinol Metab, 68, pp. 844-850
Wang, L. S., Huang, M. H., Lin, T. S., Huang, B. S., Chien, K. Y., Malignant thymomas (1992) Cancer, 70, pp. 443-450
Moina, P. L., Siergel, M. J., Glazer, H. S., Thymic mass on MR imaging (1990) Am J Roentgenol, 155, pp. 495-500
Lin, R. S., Yen, S. H., Huang, M. H., Use of fluorine-18 fluorodeoxyglucose positron emission tomography in the detection of thymoma: A preliminary report (1995) Eur J Nucl Med, 22, pp. 1402-1407
Pearse, A. G. E., The cytochemistry and ultrastructure of polypeptide hormone producing cells of the APUD series and the embryologic, physiologic and pathologic implication of the concept (1969) J Histochem Cytochem, 17, pp. 303-312
Ballard, H. S., Frame, B., Hartrock, R. J., Familial multiple endocrine adenoma-peptic ulcer complex (1964) Medicine, 43, pp. 481-516
J Nucl Med (ISSN: 0161-5505, 1535-5667, 1535-5667electronic), 1998 Apr; 39(4): 634-639.
Export to Esporta in BibTeX Export to Esporta in EndNote
Paper type Tipo di articolo: Journal Article,
Impact factor: 3.064, 5-year impact factor Impact factor a 5 anni: 5.331
Url: http://www.scopus.com/inward/record.url?eid=2-s2.0-0031948219&partnerID=40&md5=4ddf0b5e9e57b0925e62b82575ce8e14
Keywords Parole chiave: Indium-111-Octreotide, Myasthenia Gravis, Somatostatin Receptors, Thymoma, Indium 111, Pentetate Indium, Adult, Article, Cancer Staging, Clinical Article, Clinical Feature, Computer Assisted Tomography, Diagnostic Value, Female, Human, Isotope Labeling, Nuclear Magnetic Resonance Imaging, Priority Journal, Thymus Hyperplasia, Adolescent, Carcinoid Tumor, Differential, Iodine Radioisotopes, Middle Aged, Pentetic Acid, Radiopharmaceuticals, Thymus Neoplasms, Emission-Computed, Single-Photon, X-Ray Computed,
Affiliations Affiliazioni:
Via Modigliani 66/68, Aversa (CE), 81031, Italy
References Riferimenti:
Rosenberg, J.C., Neoplasms of mediastinum (1989) Cancer Principles and Practical Oncology, 3rd Ed., pp. 706-724. , De Vita VT, Hellmann S, Rosenberg SA, eds. Philadelphia: J.B. Lippincott C
Hoda, S.A., Warren, G.P., Zaman, M.B., Extrathoracic metastatic malignant thymoma diagnosis by aspiration cytology (1991) Arch Pathol Lab Med, 115, pp. 399-401
Rosai, J., Levine, G.D., Tumors of the thymus (1976) Atlas of Tumor Pathology, pp. 1-166. , Rosai J, ed. Washington, DC: Armed Forces Institute of Pathology
Chilosi, M., Iannucci, A., Fiore Donati, L., Myasthenia gravis: Immunohistological heterogeneity in microenvironmental organization of hyperplastic and neoplastic thymuses suggesting different mechanisms of tolerance breakdown (1986) J Neuroimmunol, 11, pp. 191-204
Janossy, G., BoFill, M., Trejdosiewicz, L.K., Willcox, H.N.A., Chilosi, M., Cellular differentiation of lymphoid subpopulations and their microenvironments in the human thymus (1986) The Human Thymus. Histophysiology and Pathology, pp. 89-125. , Muller-Hermelink HK, ed. Berlin: Springer
Scarpa, A., Chilosi, M., Cappelli, P., Expression and gene rearrangement of the T-cell receptor in human thymomas (1990) Virch Arch B Cell Pathol, 58, pp. 235-239
Lauriola, L., Maggiano, N., Larocca, L.M., Cells immunoreactive for neuropeptide in human thymomas (1990) J Clin Pathol, 43, pp. 829-832
Greaves, M.F., Target cells, differentiation and clonal evolution in chronic granulocytic leukemia: A model for understanding the biology of malignancy (1982) Chronic Granulocytic Leukemia, pp. 15-47. , Shaw MT, ed. New York: Praeger
Pierce, G.B., Nakane, P.K., Martinez-Hernandez, A., Ward, J.M., Ultrastructural comparison of differentiation of stem cells of murine adenocarcinomas of colon and breast with their normal counterparts (1977) J Natl Cancer Inst, 58, pp. 1329-1345
Larsson, L.I., Regulatory peptides and amines during ontogeny and in nonendocrine cancers: Occurrence and possible functional significance (1988) Prog Histochem Cytochem, 17, pp. 89-111
Zachary, J., Wol, P.J., Rozengurt, E., A role for neuropeptides in the control of cell proliferation (1987) Dev Biol, 124, pp. 295-308
Reubi, J.C., Waser, B., Horisberger, U., In vitro autoradiographic and in vivo scintigraphic localization of somatostatin receptors in human lymphatic tissue (1993) Blood, 82, pp. 2143-2151
Lamberts, S.W.J., Krenning, E.P., Reubi, J.C., The role of somatostatin and its analogues in the diagnosis and treatment of tumors (1991) Endocrinol Rev, 12, pp. 450-482
Reubi, J.C., Laissue, J., Krenning, E.P., Lamberts, S.W.J., Somatostatin receptors in human cancer: Incidence, characteristics, functional correlates and clinical implications (1992) J Steroid Biochem Mol Biol, 43, pp. 27-35
Krenning, E.P., Kwekkeboom, D.J., Bakker, W.H., Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [l23I-Tyr3]-octreotide: The Rotterdam experience with over 1000 patients (1993) Eur J Nucl Med, 20, pp. 716-731
Krenning, E.P., Bakker, W.H., Breeman, W.A.P., Localization of endocrine-related tumors with radioiodinated analogue of somatostatin (1989) Lancet, 1, pp. 242-244
Lamberts, S.W.J., Bakker, W.H., Reubi, J.C., Somatostatin receptor imaging in the localization of endocrine tumors (1990) N Engl J Med, 323, pp. 1246-1249
Lamberts, S.W.J., Chayvialle, J.A., Krenning, E.P., The visualization of gastroenteropancreatic endocrine tumors (1992) Metabolism, 9 (2 SUPPL.), pp. 111-115
Jamar, F., Fiasse, R., Leners, L., Pauwels, S., Somatostatin receptor imaging with In-111 pentetreotide in gastroenteropancreatic neuroendocrine tumors: Safety, efficacy and impact on patient management (1995) J Nucl Med, 36, pp. 542-549
Kwekkeboom, D.J., Kho, G.S., Lamberts, S.W.J., The value of octreotide scintigraphy in patients with lung cancer (1994) Eur J Nucl Med, 21, pp. 1106-1113
Flamen, P., Bossuyt, A., De Greve, J., Pipeleers-Marichal, M., Keuppens, F., Somers, G., Imaging of renal cell cancer with radiolabeled octreotide (1993) Nucl Med Commun, 14, pp. 873-877
Vanhagen, P.M., Krenning, E.P., Reubi, J.C., Somatostatin analogue scintigraphy of malignant lymphoma (1993) Br J Haematol, 83, pp. 75-79
Van Eijck, C.H., Krenning, E.P., Bootsma, A., Somatostatin receptor scintigraphy in primary breast cancer (1994) Lancet, 343, pp. 640-643
Lee, J.D., Kim, D.I., Lee, J.T., Chang, J.W., Park, C.Y., Indium-111-pentetreotide imaging in intra-axial brain tumors: Comparison with thallium-201 SPECT and MRI (1995) J Nucl Med, 36, pp. 537-541
Setyono-Han, B., Henckelman, M.S., Foekens, J.A., Klijn, J.G.M., Direct inhibitory effects of somatostatin (analogues) on the growth of human breast cancer cells (1987) Cancer Res, 47, pp. 1566-1570
Reubi, J.C., Landolt, A.M., The growth hormone responses to octreotide in acromegaly correlate with adenoma somatostatin receptor status (1991) J Clin Endocrinol Metab, 68, pp. 844-850
Wang, L.S., Huang, M.H., Lin, T.S., Huang, B.S., Chien, K.Y., Malignant thymomas (1992) Cancer, 70, pp. 443-450
Moina, P.L., Siergel, M.J., Glazer, H.S., Thymic mass on MR imaging (1990) Am J Roentgenol, 155, pp. 495-500
Sakai, F., Sine, S., Kiyono, K., MR imaging of thymoma: Radiologie-pathologie correlation (1992) Am J Roentgenol, 158, pp. 751-756
Batra, P., Hermann Jr., C., Mulder, D., Mediastinal imaging in myasthenia gravis: Correlation of chest radiography, CT, MR and surgical findings (1987) Am J Roentgenol, 148, pp. 515-519
Lin, R.S., Yen, S.H., Huang, M.H., Use of fluorine-18 fluorodeoxyglucose positron emission tomography in the detection of thymoma: A preliminary report (1995) Eur J Nucl Med, 22, pp. 1402-1407
Michigishi, T., Mizukami, Y., Shuke, N., Visualization of the thymus with therapeutic doses of radioiodine in patients with thyroid cancer (1993) Eur J Nucl Med, 20, pp. 75-79
Rettenbacher, L., Galvan, G., Differentiation between residual cancer and thymic hyperplasia in malignant non-Hodgkin's lymphoma with somatostatin receptor scintigraphy (1994) Clin Nucl Med, 19, pp. 64-65
Pearse, A.G.E., The cytochemistry and ultrastructure of polypeptide hormone producing cells of the APUD series and the embryologic, physiologic and pathologic implication of the concept (1969) J Histochem Cytochem, 17, pp. 303-312
Ballard, H.S., Frame, B., Hartrock, R.J., Familial multiple endocrine adenoma-peptic ulcer complex (1964) Medicine, 43, pp. 481-516
Palmieri, G., Lastoria, S., Colao, A., Successful treatment of a patient with malignant thymoma and pure red cell aplasia with octreotide and prednisone (1997) N Engl J Med, 336, pp. 263-265
Rosenberg, J. C., Neoplasms of mediastinum (1989) Cancer Principles and Practical Oncology, 3rd Ed., pp. 706-724. , De Vita VT, Hellmann S, Rosenberg SA, eds. Philadelphia: J. B. Lippincott C
Hoda, S. A., Warren, G. P., Zaman, M. B., Extrathoracic metastatic malignant thymoma diagnosis by aspiration cytology (1991) Arch Pathol Lab Med, 115, pp. 399-401
Greaves, M. F., Target cells, differentiation and clonal evolution in chronic granulocytic leukemia: A model for understanding the biology of malignancy (1982) Chronic Granulocytic Leukemia, pp. 15-47. , Shaw MT, ed. New York: Praeger
Pierce, G. B., Nakane, P. K., Martinez-Hernandez, A., Ward, J. M., Ultrastructural comparison of differentiation of stem cells of murine adenocarcinomas of colon and breast with their normal counterparts (1977) J Natl Cancer Inst, 58, pp. 1329-1345
Larsson, L. I., Regulatory peptides and amines during ontogeny and in nonendocrine cancers: Occurrence and possible functional significance (1988) Prog Histochem Cytochem, 17, pp. 89-111
Reubi, J. C., Waser, B., Horisberger, U., In vitro autoradiographic and in vivo scintigraphic localization of somatostatin receptors in human lymphatic tissue (1993) Blood, 82, pp. 2143-2151
Lamberts, S. W. J., Krenning, E. P., Reubi, J. C., The role of somatostatin and its analogues in the diagnosis and treatment of tumors (1991) Endocrinol Rev, 12, pp. 450-482
Reubi, J. C., Laissue, J., Krenning, E. P., Lamberts, S. W. J., Somatostatin receptors in human cancer: Incidence, characteristics, functional correlates and clinical implications (1992) J Steroid Biochem Mol Biol, 43, pp. 27-35
Krenning, E. P., Kwekkeboom, D. J., Bakker, W. H., Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1] - and [l23I-Tyr3] -octreotide: The Rotterdam experience with over 1000 patients (1993) Eur J Nucl Med, 20, pp. 716-731
Krenning, E. P., Bakker, W. H., Breeman, W. A. P., Localization of endocrine-related tumors with radioiodinated analogue of somatostatin (1989) Lancet, 1, pp. 242-244
Kwekkeboom, D. J., Kho, G. S., Lamberts, S. W. J., The value of octreotide scintigraphy in patients with lung cancer (1994) Eur J Nucl Med, 21, pp. 1106-1113
Vanhagen, P. M., Krenning, E. P., Reubi, J. C., Somatostatin analogue scintigraphy of malignant lymphoma (1993) Br J Haematol, 83, pp. 75-79
Van Eijck, C. H., Krenning, E. P., Bootsma, A., Somatostatin receptor scintigraphy in primary breast cancer (1994) Lancet, 343, pp. 640-643
Lee, J. D., Kim, D. I., Lee, J. T., Chang, J. W., Park, C. Y., Indium-111-pentetreotide imaging in intra-axial brain tumors: Comparison with thallium-201 SPECT and MRI (1995) J Nucl Med, 36, pp. 537-541
Reubi, J. C., Landolt, A. M., The growth hormone responses to octreotide in acromegaly correlate with adenoma somatostatin receptor status (1991) J Clin Endocrinol Metab, 68, pp. 844-850
Wang, L. S., Huang, M. H., Lin, T. S., Huang, B. S., Chien, K. Y., Malignant thymomas (1992) Cancer, 70, pp. 443-450
Moina, P. L., Siergel, M. J., Glazer, H. S., Thymic mass on MR imaging (1990) Am J Roentgenol, 155, pp. 495-500
Lin, R. S., Yen, S. H., Huang, M. H., Use of fluorine-18 fluorodeoxyglucose positron emission tomography in the detection of thymoma: A preliminary report (1995) Eur J Nucl Med, 22, pp. 1402-1407
Pearse, A. G. E., The cytochemistry and ultrastructure of polypeptide hormone producing cells of the APUD series and the embryologic, physiologic and pathologic implication of the concept (1969) J Histochem Cytochem, 17, pp. 303-312
Ballard, H. S., Frame, B., Hartrock, R. J., Familial multiple endocrine adenoma-peptic ulcer complex (1964) Medicine, 43, pp. 481-516
In vivo detection of malignant thymic masses by indium-111-DTPA-D- Phe1-octreotide scintigraphy
Many tumors with neuroendocrine characteristics express high amounts of somatostatin receptors that enable in vivo imaging with [111In-DTPA-D- Phe1]-octreotide. In this study, we have analyzed the feasibility in detecting and characterizing thymic masses by somatostatin receptor scintigraphy (SRS). Methods: Eighteen patients (13 women, 5 men, ages 18-78 yr; mean ± s.d. = 42.1 ± 17.6 yr) were enrolled in this study. Eleven patients were studied during diagnosis and seven during routine follow-up. In seven patients, myasthenia gravis was the presenting symptom. SRS was performed within 4 wk after CT and/or MRI. Planar and tomographic images were acquired within 24 hr after the injection of approximately 111 MBq of [111In-DTPA-D-Phe1]-octreotide. The scintigraphic results were categorized according to the histologic findings. Results: Histology diagnosed 10 mixed epithelial/lymphoid thymomas (8 with prevalent epithelial component), 2 thymic carcinomas, 1 thymic carcinoid, 1 lymphangioma and 4 thymic hyperplasias. Two thymoma were Stage I, 3 were Stage II, 2 were Stage III and 5 were Stage IV, as was the thymic carcinoid. Indium-111-DTPA-D- Phe1-octreotide concentrated in primary and/or metastatic sites of thymic tumors, thereby enabling successful external gamma imaging of sites greater than 1.5 cm in size. Tumor-to-lung (T/L) ratios were as high as 7.6-fold (range 1.7-7.6). Untreated thymomas showed higher T/L (4.34 ± 1.57) than treated ones (2.68 ± 1.18). No uptake was detectable in the four patients with benign thymic hyperplasia and the patient with the lymphangioma. Conclusion: Indium-111-DTPA-D-Phe1-octreotide is avidly concentrated within thymic tumors, but it is not concentrated by thymic hyperplasia, which allows differential diagnosis. Thus, in patients with myasthenia gravis, SRS may have a role in characterizing thymic masses, thereby overcoming the limits of cross-sectional imaging modalities.
Many tumors with neuroendocrine characteristics express high amounts of somatostatin receptors that enable in vivo imaging with [111In-DTPA-D- Phe1]-octreotide. In this study, we have analyzed the feasibility in detecting and characterizing thymic masses by somatostatin receptor scintigraphy (SRS). Methods: Eighteen patients (13 women, 5 men, ages 18-78 yr; mean ± s.d. = 42.1 ± 17.6 yr) were enrolled in this study. Eleven patients were studied during diagnosis and seven during routine follow-up. In seven patients, myasthenia gravis was the presenting symptom. SRS was performed within 4 wk after CT and/or MRI. Planar and tomographic images were acquired within 24 hr after the injection of approximately 111 MBq of [111In-DTPA-D-Phe1]-octreotide. The scintigraphic results were categorized according to the histologic findings. Results: Histology diagnosed 10 mixed epithelial/lymphoid thymomas (8 with prevalent epithelial component), 2 thymic carcinomas, 1 thymic carcinoid, 1 lymphangioma and 4 thymic hyperplasias. Two thymoma were Stage I, 3 were Stage II, 2 were Stage III and 5 were Stage IV, as was the thymic carcinoid. Indium-111-DTPA-D- Phe1-octreotide concentrated in primary and/or metastatic sites of thymic tumors, thereby enabling successful external gamma imaging of sites greater than 1.5 cm in size. Tumor-to-lung (T/L) ratios were as high as 7.6-fold (range 1.7-7.6). Untreated thymomas showed higher T/L (4.34 ± 1.57) than treated ones (2.68 ± 1.18). No uptake was detectable in the four patients with benign thymic hyperplasia and the patient with the lymphangioma. Conclusion: Indium-111-DTPA-D-Phe1-octreotide is avidly concentrated within thymic tumors, but it is not concentrated by thymic hyperplasia, which allows differential diagnosis. Thus, in patients with myasthenia gravis, SRS may have a role in characterizing thymic masses, thereby overcoming the limits of cross-sectional imaging modalities.
In vivo detection of malignant thymic masses by indium-111-DTPA-D- Phe1-octreotide scintigraphy
No results. Nessun risultato. |
In vivo detection of malignant thymic masses by indium-111-DTPA-D- Phe1-octreotide scintigraphy
Accardo A, Mansi R, Salzano G, Morisco A, Aurilio M, Parisi A, Maione F, Cicala C, Ziaco B, Tesauro D, Aloj L, De Rosa G, Morelli G
* Bombesin peptide antagonist for target-selective delivery of liposomal doxorubicin on cancer cells (373 visite)
Journal Of Drug Targeting (ISSN: 1061-186x), 2012 Nov 21; 21(3): 240-249.
Impact Factor: 2.768
Dettagli Esporta in BibTeX Esporta in EndNote
Tornesello AL, Aurilio M, Accardo A, Tarallo L, Barbieri A, Arra C, Tesauro D, Morelli G, Aloj L
* Gastrin and cholecystokinin peptide-based radiopharmaceuticals: An in vivo and in vitro comparison (360 visite)
J Pept Sci (ISSN: 1075-2617, 1099-1387, 1075-2617print), 2011 May; 17(5): 405-412.
Impact Factor: 1.799
Dettagli Esporta in BibTeX Esporta in EndNote
Zannetti A, Del Vecchio S, Iommelli F, Del Gatto A, De Luca S, Zaccaro L, Papaccioli A, Sommella J, Panico M, Speranza A, Grieco P, Novellino E, Saviano M, Pedone C, Salvatore M
* Imaging of αvβ3 expression by a bifunctional chimeric RGD peptide not cross-reacting with α vβ5 (796 visite)
Clin Cancer Res (ISSN: 1078-0432, 1078-0432linking, 1078-0432print), 2009 Sep 15; 15(16): 5224-5233.
Impact Factor: 6.747
Dettagli Esporta in BibTeX Esporta in EndNote
Storto G, Erra P, Pellegrino T, Nardelli A, Milone F, Di Giorgio E, Faggiano A, Castaldi E, Ortosecco G, Speranza A, Klain M, Colao A, Salvatore M, Pace L
* Efficacy and Toxicity of Peptide Receptor Radionuclide Therapy (PRRT) using medium-high activities of Y-90-DOTA-Octreotate (Y-90-DOTATATE) in patients with tumours expressing somatostatin receptors (SSTR) (227 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2008 Oct; 35: N/D-N/D.
Impact Factor: 4.532
Dettagli Esporta in BibTeX Esporta in EndNote
Del Vecchio S, Zannetti A, Fonti R, Pace L, Salvatore M
* Nuclear imaging in cancer theranostics (566 visite)
Q J Nucl Med Mol Im (ISSN: 1824-4785, 1824-4478, 1824-4785linking), 2007 Jun; 51(2): 152-163.
Impact Factor: 1.724
Dettagli Esporta in BibTeX Esporta in EndNote
Aloj L, Aurilio M, Rinaldi V, D'Ambrosio L, Tesauro D, Peitl PK, Maina T, Mansi R, Von Guggenberg E, Joosten L, Sosabowski JK, Breeman WA, De Blois E, Koelewijn S, Melis M, Waser B, Beetschen K, Reubi JC, De Jong M
* The EEE project (431 visite)
Proc Int Cosm Ray Conf Icrc Universidad Nacional Autonoma De Mexico, 2007; 5(HEPART2): 977-980.
Impact Factor: 0
Dettagli Esporta in BibTeX Esporta in EndNote
De Luca S, Morelli G
* Synthesis and characterization of a sulfated and a non-sulfated cyclic CCK8 analogue functionalized with a chelating group for metal labelling (354 visite)
J Pept Sci (ISSN: 1075-2617, 1099-1387, 1075-2617print), 2004 May; 10(5): 265-273.
Impact Factor: 1.652
Dettagli Esporta in BibTeX Esporta in EndNote
Aloj L, Caracò C, Panico M, Zannetti A, Del Vecchio S, Tesauro D, De Luca S, Arra C, Pedone C, Morelli G, Salvatore M
* In vitro and in vivo evaluation of In-111-DTPAGlu-G-CCK8 for cholecystokinin-B receptor imaging (543 visite)
J Nucl Med (ISSN: 1535-5667, 0161-5505, 1535-5667electronic), 2004 Mar; 45(3): 485-494.
Impact Factor: 5.362
Dettagli Esporta in BibTeX Esporta in EndNote
Aloj L, Panico M, Caraco C, Del Vecchio S, Arra C, Affuso A, Accardo A, Mansi R, Tesauro D, De Luca S, Pedone C, Visentin R, Mazzi U, Morelli G, Salvatore M
* In vitro and in vivo characterization of Indium-111 and Technetium-99m labeled CCK-8 derivatives for CCK-B receptor imaging (462 visite)
Cancer Biotherapy And Radiopharmaceuticals (ISSN: 1084-9785, 1084-4978), 2004 Feb; 19(1): 93-98.
Impact Factor: 1.091
Dettagli Esporta in BibTeX Esporta in EndNote
Mansi R, Tesauro D, De Capua A, Fattorusso R, Carac C, Aloj L, Benedetti E, Morelli G
* Peptide-chelating agent conjugate for selective targeting of somatostatin receptor type 1: Synthesis and characterization (425 visite)
Biopolymers (ISSN: 0006-3525, 0006-6352, 0006-3525print), 2004; 76(6): 527-534.
Impact Factor: 2.863
Dettagli Esporta in BibTeX Esporta in EndNote
Aloj L, Panico M, Caracó C, Zannetti A, Del Vecchio S, Di Nuzzo C, Arra C, Morelli G, Tesauro D, De Luca S, Pedone C, Salvatore M
* Radiolabeling approaches for cholecystokinin B receptor imaging (471 visite)
Biopolymers (ISSN: 0006-3525, 0006-6352, 0006-3525print), 2002; 66(6): 370-380.
Impact Factor: 2.372
Dettagli Esporta in BibTeX Esporta in EndNote
De Luca S, Tesauro D, Di Lello P, Fattorusso R, Saviano M, Pedone C, Morelli G
* Synthesis and solution characterization of a porphyrin-CCK8 conjugate (420 visite)
J Pept Sci (ISSN: 1075-2617, 1099-1387, 1075-2617print), 2001 Jul; 7(7): 386-394.
Impact Factor: 1.451
Dettagli Esporta in BibTeX Esporta in EndNote
Camera L, Brunetti A, Romano M, Larobina M, Marano I, Salvatore M
Morphological imaging of thymic disorders (251 visite)
Ann Med (ISSN: 0785-3890), 1999 Oct; 31(SUPPL.2): 57-62.
Impact Factor: 2.566
Dettagli Esporta in BibTeX Esporta in EndNote
Colao A, Lastoria S, Ferone D, Varrella P, Marzullo P, Pivonello R, Cerbone G, Acampa W, Salvatore M, Lombardi G
The pituitary uptake of In-111-DTPA-D-Phe(1)-octreotide in the normal pituitary and in pituitary adenomas (358 visite)
J Endocrinol Invest (ISSN: 0391-4097, 1720-8386electronic), 1999 Mar; 22(3): 176-183.
Impact Factor: 0.957
Dettagli Esporta in BibTeX Esporta in EndNote
Renda A, Iovino F, Capasso L, Ricciardelli L, Tammaro V, Acampa W
Radioimmunoguided surgery in colorectal cancer: A 6-year experience with four different technical solutions (254 visite)
Semin Surg Oncol Wiley Liss Inc (ISSN: 8756-0437), 1998 Dec; 15(4): 226-230.
Impact Factor: 1.045
Dettagli Esporta in BibTeX Esporta in EndNote
Maurea S, Lastoria S, Caracò C, Klain M, Varrella P, Acampa W, Muto P, Salvatore M
The role of radiolabeled somatostatin analogs in adrenal imaging (310 visite)
Nucl Med Biol (ISSN: 0969-8051, 0883-2897), 1996 Sep; 23(6): 677-680.
Impact Factor: 1.042
Dettagli Esporta in BibTeX Esporta in EndNote
Lastoria S, Maurea S, Vergara E, Acampa W, Varrella P, Klain M, Muto P, Bernardy JD, Salvatore M
Comparison of labeled MIBG and somatostatin analogs in imaging neuroendocrine tumors (308 visite)
Q J Nucl Med (ISSN: 1125-0135, 1124-3937), 1995 Dec; 39(4Suppl1): 145-149.
Impact Factor: 2.125
Dettagli Esporta in BibTeX Esporta in EndNote
LASTORIA S, VERGARA E, VARRELLA P, ACAMPA W, PALMIERI G, SALVATORE M
IN-VIVO DETECTION OF NEW DISEASES EXPRESSING SOMATOSTATIN RECEPTORS BY IN-111 OCTREOTIDE (235 visite)
J Nucl Med (ISSN: 0161-5505, 1535-5667, 1535-5667electronic), 1994 May; 35(5): N/D-N/D.
Impact Factor: 3.491
Dettagli Esporta in BibTeX Esporta in EndNote
LASTORIA S, VERGARA E, VARRELLA P, ACAMPA W, PALMIERI G, SALVATORE M
IN-VIVO DETECTION OF NEW NEOPLASTIC LESIONS EXPRESSING SOMATOSTATIN RECEPTORS USING IN-111 OCTREOTIDE (258 visite)
Posters Tomes 1 4proceedings Of The Xvi International Cancer Congress Free Papers And, 1994; N/D: N/D-N/D.
Impact Factor: 0
Dettagli Esporta in BibTeX Esporta in EndNote
19 Records (16 escludendo Abstract e Conferenze).
Impact factor totale: 43.587 (35.564 escludendo Abstract e Conferenze).
Impact factor a 5 anni totale: 50.684 (40.728 escludendo Abstract e Conferenze).
Vai a fine pagina Versione per copia e incolla facile Esporta tutto in BibTeX Esporta tutto in EndNote
Accardo A, Mansi R, Salzano G, Morisco A, Aurilio M, Parisi A, Maione F, Cicala C, Ziaco B, Tesauro D, Aloj L, De Rosa G, Morelli G
* Bombesin peptide antagonist for target-selective delivery of liposomal doxorubicin on cancer cells (373 visite)
Journal Of Drug Targeting (ISSN: 1061-186x), 2012 Nov 21; 21(3): 240-249.
Impact Factor: 2.768
Dettagli Esporta in BibTeX Esporta in EndNote
Tornesello AL, Aurilio M, Accardo A, Tarallo L, Barbieri A, Arra C, Tesauro D, Morelli G, Aloj L
* Gastrin and cholecystokinin peptide-based radiopharmaceuticals: An in vivo and in vitro comparison (360 visite)
J Pept Sci (ISSN: 1075-2617, 1099-1387, 1075-2617print), 2011 May; 17(5): 405-412.
Impact Factor: 1.799
Dettagli Esporta in BibTeX Esporta in EndNote
Zannetti A, Del Vecchio S, Iommelli F, Del Gatto A, De Luca S, Zaccaro L, Papaccioli A, Sommella J, Panico M, Speranza A, Grieco P, Novellino E, Saviano M, Pedone C, Salvatore M
* Imaging of αvβ3 expression by a bifunctional chimeric RGD peptide not cross-reacting with α vβ5 (796 visite)
Clin Cancer Res (ISSN: 1078-0432, 1078-0432linking, 1078-0432print), 2009 Sep 15; 15(16): 5224-5233.
Impact Factor: 6.747
Dettagli Esporta in BibTeX Esporta in EndNote
Storto G, Erra P, Pellegrino T, Nardelli A, Milone F, Di Giorgio E, Faggiano A, Castaldi E, Ortosecco G, Speranza A, Klain M, Colao A, Salvatore M, Pace L
* Efficacy and Toxicity of Peptide Receptor Radionuclide Therapy (PRRT) using medium-high activities of Y-90-DOTA-Octreotate (Y-90-DOTATATE) in patients with tumours expressing somatostatin receptors (SSTR) (227 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2008 Oct; 35: N/D-N/D.
Impact Factor: 4.532
Dettagli Esporta in BibTeX Esporta in EndNote
Del Vecchio S, Zannetti A, Fonti R, Pace L, Salvatore M
* Nuclear imaging in cancer theranostics (566 visite)
Q J Nucl Med Mol Im (ISSN: 1824-4785, 1824-4478, 1824-4785linking), 2007 Jun; 51(2): 152-163.
Impact Factor: 1.724
Dettagli Esporta in BibTeX Esporta in EndNote
Aloj L, Aurilio M, Rinaldi V, D'Ambrosio L, Tesauro D, Peitl PK, Maina T, Mansi R, Von Guggenberg E, Joosten L, Sosabowski JK, Breeman WA, De Blois E, Koelewijn S, Melis M, Waser B, Beetschen K, Reubi JC, De Jong M
* The EEE project (431 visite)
Proc Int Cosm Ray Conf Icrc Universidad Nacional Autonoma De Mexico, 2007; 5(HEPART2): 977-980.
Impact Factor: 0
Dettagli Esporta in BibTeX Esporta in EndNote
De Luca S, Morelli G
* Synthesis and characterization of a sulfated and a non-sulfated cyclic CCK8 analogue functionalized with a chelating group for metal labelling (354 visite)
J Pept Sci (ISSN: 1075-2617, 1099-1387, 1075-2617print), 2004 May; 10(5): 265-273.
Impact Factor: 1.652
Dettagli Esporta in BibTeX Esporta in EndNote
Aloj L, Caracò C, Panico M, Zannetti A, Del Vecchio S, Tesauro D, De Luca S, Arra C, Pedone C, Morelli G, Salvatore M
* In vitro and in vivo evaluation of In-111-DTPAGlu-G-CCK8 for cholecystokinin-B receptor imaging (543 visite)
J Nucl Med (ISSN: 1535-5667, 0161-5505, 1535-5667electronic), 2004 Mar; 45(3): 485-494.
Impact Factor: 5.362
Dettagli Esporta in BibTeX Esporta in EndNote
Aloj L, Panico M, Caraco C, Del Vecchio S, Arra C, Affuso A, Accardo A, Mansi R, Tesauro D, De Luca S, Pedone C, Visentin R, Mazzi U, Morelli G, Salvatore M
* In vitro and in vivo characterization of Indium-111 and Technetium-99m labeled CCK-8 derivatives for CCK-B receptor imaging (462 visite)
Cancer Biotherapy And Radiopharmaceuticals (ISSN: 1084-9785, 1084-4978), 2004 Feb; 19(1): 93-98.
Impact Factor: 1.091
Dettagli Esporta in BibTeX Esporta in EndNote
Mansi R, Tesauro D, De Capua A, Fattorusso R, Carac C, Aloj L, Benedetti E, Morelli G
* Peptide-chelating agent conjugate for selective targeting of somatostatin receptor type 1: Synthesis and characterization (425 visite)
Biopolymers (ISSN: 0006-3525, 0006-6352, 0006-3525print), 2004; 76(6): 527-534.
Impact Factor: 2.863
Dettagli Esporta in BibTeX Esporta in EndNote
Aloj L, Panico M, Caracó C, Zannetti A, Del Vecchio S, Di Nuzzo C, Arra C, Morelli G, Tesauro D, De Luca S, Pedone C, Salvatore M
* Radiolabeling approaches for cholecystokinin B receptor imaging (471 visite)
Biopolymers (ISSN: 0006-3525, 0006-6352, 0006-3525print), 2002; 66(6): 370-380.
Impact Factor: 2.372
Dettagli Esporta in BibTeX Esporta in EndNote
De Luca S, Tesauro D, Di Lello P, Fattorusso R, Saviano M, Pedone C, Morelli G
* Synthesis and solution characterization of a porphyrin-CCK8 conjugate (420 visite)
J Pept Sci (ISSN: 1075-2617, 1099-1387, 1075-2617print), 2001 Jul; 7(7): 386-394.
Impact Factor: 1.451
Dettagli Esporta in BibTeX Esporta in EndNote
Camera L, Brunetti A, Romano M, Larobina M, Marano I, Salvatore M
Morphological imaging of thymic disorders (251 visite)
Ann Med (ISSN: 0785-3890), 1999 Oct; 31(SUPPL.2): 57-62.
Impact Factor: 2.566
Dettagli Esporta in BibTeX Esporta in EndNote
Colao A, Lastoria S, Ferone D, Varrella P, Marzullo P, Pivonello R, Cerbone G, Acampa W, Salvatore M, Lombardi G
The pituitary uptake of In-111-DTPA-D-Phe(1)-octreotide in the normal pituitary and in pituitary adenomas (358 visite)
J Endocrinol Invest (ISSN: 0391-4097, 1720-8386electronic), 1999 Mar; 22(3): 176-183.
Impact Factor: 0.957
Dettagli Esporta in BibTeX Esporta in EndNote
Renda A, Iovino F, Capasso L, Ricciardelli L, Tammaro V, Acampa W
Radioimmunoguided surgery in colorectal cancer: A 6-year experience with four different technical solutions (254 visite)
Semin Surg Oncol Wiley Liss Inc (ISSN: 8756-0437), 1998 Dec; 15(4): 226-230.
Impact Factor: 1.045
Dettagli Esporta in BibTeX Esporta in EndNote
Maurea S, Lastoria S, Caracò C, Klain M, Varrella P, Acampa W, Muto P, Salvatore M
The role of radiolabeled somatostatin analogs in adrenal imaging (310 visite)
Nucl Med Biol (ISSN: 0969-8051, 0883-2897), 1996 Sep; 23(6): 677-680.
Impact Factor: 1.042
Dettagli Esporta in BibTeX Esporta in EndNote
Lastoria S, Maurea S, Vergara E, Acampa W, Varrella P, Klain M, Muto P, Bernardy JD, Salvatore M
Comparison of labeled MIBG and somatostatin analogs in imaging neuroendocrine tumors (308 visite)
Q J Nucl Med (ISSN: 1125-0135, 1124-3937), 1995 Dec; 39(4Suppl1): 145-149.
Impact Factor: 2.125
Dettagli Esporta in BibTeX Esporta in EndNote
LASTORIA S, VERGARA E, VARRELLA P, ACAMPA W, PALMIERI G, SALVATORE M
IN-VIVO DETECTION OF NEW DISEASES EXPRESSING SOMATOSTATIN RECEPTORS BY IN-111 OCTREOTIDE (235 visite)
J Nucl Med (ISSN: 0161-5505, 1535-5667, 1535-5667electronic), 1994 May; 35(5): N/D-N/D.
Impact Factor: 3.491
Dettagli Esporta in BibTeX Esporta in EndNote
LASTORIA S, VERGARA E, VARRELLA P, ACAMPA W, PALMIERI G, SALVATORE M
IN-VIVO DETECTION OF NEW NEOPLASTIC LESIONS EXPRESSING SOMATOSTATIN RECEPTORS USING IN-111 OCTREOTIDE (258 visite)
Posters Tomes 1 4proceedings Of The Xvi International Cancer Congress Free Papers And, 1994; N/D: N/D-N/D.
Impact Factor: 0
Dettagli Esporta in BibTeX Esporta in EndNote
19 Records (16 escludendo Abstract e Conferenze).
Impact factor totale: 43.587 (35.564 escludendo Abstract e Conferenze).
Impact factor a 5 anni totale: 50.684 (40.728 escludendo Abstract e Conferenze).
Last modified by Ultima modifica di Marco Comerci on in data Sunday 12 July 2020, 13:15:14
396 views visite. Last view on Ultima visita in data Thursday 02 September 2021, 20:30:48
ibb.cnr.it